# Trilitas

NDC: 87143-200
Generic name: TAZAROTENE
Labeler / Manufacturer: Perfero Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20260615

FDA application: ANDA214136

## Active ingredients

- TAZAROTENE: 1 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87143-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87143-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cf1faef-73b8-4ab2-a4c8-521f0bd3fc10